ตำรามาตรฐานยาสมุนไพรไทย
Thai Herbal Pharmacopoeia
สำนักยาและวัตถุเสพติด กรมวิทยาศาสตร์การแพทย์ กระทรวงสาธารณสุข
Bureau of Drug and Narcotic, Department of Medical Sciences, Ministry of Public Health(Tinospora crispa (L.) Hook.f. & Thomson)
(Nelumbo nucifera Gaertn.)
(Centella asiatica (L.) Urb.)
(Centella Dry Extract)
(Centella Cream)
(Mesua ferrea L.)
(Piper sarmentosum Roxb.)
(Piper sarmentosum Roxb.)
(Pterocarpus santalinus L. f.)
(Santalum album L.)
(Senna tora (L.) Roxb.)
(Senna alata (L.) Roxb.)
(Senna Alata Tea)
(Piper retrofractum Vahl)
(Myristica fragrans Houtt)
(Andrographis paniculata (Burm. f.) Nees)
(Andrographis Capsules)
(Allium ascalonicum L.)
(Ocimum tenuiflorum L.)
(Curcuma longa L.)
(Turmeric Capsules)
(Turmeric Dry Extract)
(Turmeric Dry Extract Capsules)
(Arcangelisia flava (L.) Merr.)
(Curcuma sp.)
Harrisonia perforata (Blanco) Merr.
(Aristolochia pierrei Lecomte)
(Zingiber officinale Roscoe)
(Ginger Capsules)
(Ginger Tea)
(Cassia fistula L.)
(Nardostachys jatamansi (D. Don) DC.)
(Angelica sinensis (Oliv.) Diels)
Artemisia annua L.
(Ligusticum sinense Oliv. cv. Chuanxiong)
(Neopicrorhiza scrophulariiflora Pennell)
(Atractylodes lancea (Thunb.) DC.)
(Aucklandia lappa Decne)
(Terminalia chebula Retz.)
(Angelica dahurica (Hoffm.) Benth. & Hook. f. ex Franch. & Sav. var. dahurica)
(Kaempferia parviflora Wall. ex Baker)
(Hibiscus sabdariffa L.)
(Roselle Tea)
(Allium sativum L.)
(Zingiber zerumbet (L.) Sm.)
(Wurfbainia testacea (Ridl.) Škorničk.& A. D. Poulsen)
(Cannabis sativa L.)
(Myristica fragrans Houtt)
(Dracaena cochinchinensis (Lour.) S. C. Chen)
(Ficus racemosa L.)
(Hyptis suaveolens (L.) Poit.)
Clerodendrum indicum (L.) Kuntze
(Phyllanthus emblica L.)
(Citrus hystrix DC.)
(Citrus hystrix DC.)
(Areca catechu L.)
(Momordica charantia L.)
Moringa oleifera Lam.
(Aegle marmelos (L.) Corrêa)
(Solanum trilobatum L.)
(Morus alba L.)
Gynostemma pentaphyllum(Thunb.)
Makino
(Clinacanthus nutans (Burm. f.) Lindau)
(Cissus quadrangularis L.)
(Mimusops elengi L.)
(Zingiber montanum (J. König) Link. ex A. Dietr.)
(Piper betle L.)
(Capsicum annuum L.)
(Capsicum Oleoresin)
(Capsicum Gel)
(Piper nigrum L.)
(Piper nigrum L.)
(Eurycoma longifolia Jack)
(Thunbergia laurifolia Lindl.)
(Piper wallichii (Miq.) Hand.-Mazz.)
Senna garrettiana (Craib) H. S. Irwin & Barneby
(Terminalia bellirica (Gaertn.) Roxb.)
(Terminalia chebula Retz.)
(Caesalpinia bonduc (L.) H. Roxb.)
(Tarlmounia elliptica (DC.) H. Rob., S. C. Keeley, Skvaria & R. Chan)
(Hog Creeper Vine Dry Extract Capsiles)
(Hog Creeper Vine Dry Extract)
(Brachypterum scandens (Roxb.) Miq.)
(Lepidium sativum L.)
(Nigella sativa L.)
(Cuminum cyminum L.)
(Foeniculum vulgare Mill.)
(Plantago ovata Forssk.)
(Pimpinella anisum L.)
(Carum carvi L.)
(Anethum graveolens L.)
(Trachyspermum ammi (L.) Sprague)
Albizia procera (Roxb.) Benth.
(Acorus calamus L.)
(Tiliacora triandra (Colebr.) Diels)
Cyanthillium cinereum (L.) H. Rob.
(Orthosiphon aristatus (Blume) Miq.)
Murdannia loriformis (Hassk.) R. S. Rao & Kammathy
(Capparis micracantha DC.)
(Chrysopogon zizanioides (L.) Roberty)
(Cyperus rotundus L.)
(Cannabis sativa L.)
(Syzygium aromaticum (L.) Merr. & L. M. Perry)
(Boesenbergia rotunda (L.) Mansf.)
(Acanthus ebracteatus Vahl)
(Acanthus ilicifolius L.)
(Kaempferia galanga L.)
(Curcuma comosa Roxb.)
Betula alnoides Buch.-Ham. ex D. Don
Cannabis sativa L.
Carthamus tinctorius L
Mitragyna speciosa (Korth.) Havil
Mallotus repandus (Rottler) Müll. Arg
Azadirachta indica A. Juss. var. siamensis Valeton
Azadirachta indica A. Juss. var. siamensis Valeton
Punica granatum L.
Rhinacanthus nasutus (L.) Kurz
Baliospermum solanifolium (Burm.) Suresh
Curcuma aeruginosa Roxb
Boesenbergia kingii Mood & L. M. Prince
Senegalia rugata (Lam.) Britton & Rose
Acacia concinna (Willd.) DC.
Senegalia rugata (Lam.) Britton & Rose
Acacia concinna (Willd.) DC.
Senna alexandriana Mill. var. alexandriana
Cassia acutifolia Delile, Cassia angustifolia Vahl
Butea superba Roxb. ex Willd.
[Plaso superba (Roxb. ex Willd.) Kuntze, Rudolphia superba (Roxb. ex Willd.) Poir.
Pueraria candollei Graham
ex Benth. var. mirifica (Airy Shaw & Suvat.) Niyomdham
Streblus asper Lour.
Suregada multiflora (A. Juss.) Baill. (Gelonium
multiflorum A. Juss.
In the manufacturing, packaging, storage and distribution of pharmaceutical preparations, suitable means must be taken to ensure their microbiological quality. Unless otherwise specified in the individual monograph, the non-sterile pharmaceutical preparations should comply with the acceptance criteria given in Table 1, and the herbal drug preparations should comply with the acceptance criteria given in Table 2. Tables 1 and 2 include a list of specified micro-organisms for which acceptance criteria are set. The list is not necessarily exhaustive and for a given preparation it may be necessary to test for other micro-organisms depending on the nature of the starting materials and the manufacturing process.
Table 1 Acceptance Criteria for Microbiological Quality of Non-sterile Pharmaceutical Preparations
Category | Types | Requirements* |
1 | Topical preparations for broken skins, abscess, lesions, and mucous membranes excluding vaginal and rectal routes | - Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL. - Absence of Pseudomonas aeruginosa and Staphylococcus aureus per g or per mL |
2 | A. Preparations for inhalation use (Applied to liquid preparations for nebulization) |
- Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL. - Absence of bile-tolerant gram-negative bacteria, Pseudomonas aeruginosa and Staphylococcus aureus per g or per mL. |
B. Preparations for vaginal use | - Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL. - Absence of Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans per g or per mL. |
*Carry out the tests as described in the “Microbial Limit Tests” (Appendix 10.2).
Table 1 (continued)
Category | Types | Requirements* |
2 | C. Preparation for rectal use | - Total aerobic microbial count: not more than 2 × 103 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 102 CFU per g or per mL. |
D. Preparations for nasal use (Applied to liquid, semi-solid or solid preparations for administration to the nostrils) |
- Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL. - Absence of Pseudomonas aeruginosa and Staphylococcus aureus per g or per mL. |
|
E. Preparations for auricular, gingival and oromucosal use |
- Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL. - Absence of Pseudomonas aeruginsa and Staphylococcus aureus per g or per mL. |
|
3 | Transdermal patches and topical preparations for intact skin, e.g., creams, lotions, ointments, solutions, powders, etc. | - Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL or per patch and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL or per patch. - Absence of Pseudomonas aeruginosa and Staphylococcus aureus per g or per mL or per patch. |
4 | A. Aqueous preparations for oral use | - Total aerobic microbial count: not more than 2 × 102 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 101 CFU per g or per mL. - Absence of Escherichia coli per g or per mL |
*Carry out the tests as described in the “Microbial Limit Tests” (Appendix 10.2).
Table 1 (continued)
Category | Types | Requirements* |
B. Non-aqueous preparations for oral use | - Total aerobic microbial count: not more than 2 × 103 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 102 CFU per g or per mL. - Absence of Escherichia coli per g or per mL |
|
5 | Preparations for oral administration containing raw materials of natural origin (animal, vegetable or mineral) which cannot be treated with a process for reduction of microbial count** |
- Total aerobic microbial count: not more than 2 × 104 CFU per g or per mL and total combined yeasts and moulds count: not more than 2 × 102 CFU per g or per mL. - Bile-tolerant gram-negative bacteria: not more than 102 probable number of bacteria per g or per mL. - Absence of Staphylococcus aureus and Escherichia coli per g or per mL. - Absence of Salmonella spp. per 10 g or per 10 mL. |
*Carry out the tests as described in the “Microbial Limit Tests” (Appendix 10.2).
**Specified for raw materials of natural origin that are not obtainable with the required purity including those for manufacturing drugs where an antimicrobial treatment (e.g., with ethylene oxide or ionizing radiations) is not feasible or permissible. The examples are arabic gum, tragacanth, pancreas powder, pepsin, and trypsin
Table 2 Acceptance Criteria for Microbiological Quality of Herbal Drug Preparations
Category | Types | Requirements* |
1 | Preparations from crude drug extracts which underwent a process for reduction of micro-organisms: A. Preparations for oral use |
- Total aerobic microbial count: not more than 5 × 104 CFU per g or per mL and total combined yeasts and moulds count: not more than 5 × 102 CFU per g or per mL. - Bile-tolerant gram-negative bacteria: not more than102 probable number of bacteria per g or per mL. - Absence of Escherichia coli per g or per mL. - Absence of Salmonella spp. per 25 g or per 25 mL. |
B. Topical preparations for intact skin | - Meet the requirements stated in Table 1 Category 3. | |
2 | Preparations of crude drugs and mixtures of crude drugs for internal use which will undergo a process for reduction of microbial count before use (e.g., by pouring boiling water over them) | - Total aerobic microbial count: not more than 5 × 107 CFU per g or per mL and total combined yeasts and moulds count: not more than 5 × 105 CFU per g or per mL. - Escherichia coli: not more than 103 CFU per g or per mL. - Absence of Clostridium spp. per g or per mL. - Absence of Salmonella spp. per 25 g or per 25 mL. |
3 | Preparations for external use of crude drugs and mixtures of crude drugs A. Applied to herbal compress (LUK PRAKHOP) |
- Total aerobic microbial count: not more than 5 × 107 CFU per g or per mL and total combined yeasts and moulds count: not more than 5 × 105 CFU per g or per mL. - Absence of Pseudomonas aeruginosa, Staphylococcus aureus and Clostridium spp. per g or per mL. |
B. Applied to others, i.e., herbal inhalant (YAA DOM SAMUN PHRAI), herbal insufflation (YAA NAT) |
- Meet the requirements stated in Table 1 Category 3. |
*Carry out the tests as described in the “Microbial Limit Tests” (Appendix 10.2).
Table 2 (Continued)
Category | Types | Requirements* |
4 | Other preparations for internal use containing whole or ground crude drugs | - Total aerobic microbial count: not more than 5 × 105 CFU per g or per mL and total combined yeasts and moulds count: not more than 5 × 104 CFU per g or per mL. - Bile-tolerant gram-negative bacteria: not more than 102 probable number of bacteria per g or per mL. - Absence of Escherichia coli and Clostridium spp. per g or per mL. - Absence of Salmonella spp. per 25 g or per 25 mL. |
*Carry out the tests as described in the “Microbial Limit Tests” (Appendix 10.2).